Learn more →
Back to Expert Scholars
clinical / clinicalPediatric Oncology

Giles Robinson

贾尔斯·鲁滨逊

MD

🏢St. Jude Children's Research Hospital(圣裘德儿童研究医院)🌐USA

Associate Member, Department of Oncology; Director, Medulloblastoma Program肿瘤学系副研究员;髓母细胞瘤项目主任

44
h-index
3
Key Papers
5
Awards
3
Key Contributions

👥Biography 个人简介

Giles Robinson is a leading pediatric oncologist at St. Jude specializing in medulloblastoma clinical trials, who pioneered vismodegib and sonidegib SHH inhibitor studies in pediatric SHH-medulloblastoma and leads risk-stratified treatment reduction trials to minimize long-term toxicity in favorable-risk patients.

Share:

🧪Research Fields 研究领域

Pediatric Medulloblastoma儿童髓母细胞瘤
SHH Pathway InhibitorsSHH通路抑制剂
Vismodegib/Sonidegib Trials维莫德吉/索尼德吉临床试验
Risk-Adapted Therapy风险适应性治疗

🎓Key Contributions 主要贡献

SHH Inhibitor Clinical Trials

Led phase I/II trials of vismodegib and sonidegib in pediatric SHH-medulloblastoma, defining pharmacokinetics, toxicity profiles, and efficacy in this molecularly defined subgroup.

Risk-Adapted Therapy Reduction

Leads SJMB12 and related St. Jude trials testing reduced-dose radiotherapy and chemotherapy in low-risk medulloblastoma to preserve neurocognitive outcomes without sacrificing survival.

Molecular Subgroup-Guided Treatment

Established molecular subgroup assignment as a clinical standard at St. Jude, enabling prospective subgroup-specific treatment allocation in newly diagnosed medulloblastoma.

Representative Works 代表性著作

[1]

Vismodegib exerts targeted efficacy against recurrent Sonic Hedgehog-subgroup medulloblastoma

Journal of Clinical Oncology (2015)

Demonstrated targeted clinical activity of vismodegib in SHH-medulloblastoma, supporting molecularly guided treatment.

[2]

Risk-adapted craniospinal irradiation in pediatric medulloblastoma: SJMB12 trial

Lancet Oncology (2022)

Landmark trial demonstrating safety of reduced-dose craniospinal irradiation in favorable-risk medulloblastoma subgroups.

[3]

Molecular subgroups of medulloblastoma: the current consensus

Acta Neuropathologica (2020)

International consensus statement on medulloblastoma molecular subgroups and their clinical implications for therapy.

🏆Awards & Recognition 奖项与荣誉

🏆St. Jude Excellence in Research Award
🏆ASPHO Young Investigator Award
🏆Pediatric Cancer Research Foundation Award
🏆PBTF Innovator Award
🏆ASCO Merit Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 贾尔斯·鲁滨逊 的研究动态

Follow Giles Robinson's research updates

留下邮箱,当我们发布与 Giles Robinson(St. Jude Children's Research Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment